BD Appoints J&J Vision Exec Peter Menziuso as President of Interventional

BD (Becton, Dickinson and Company) has named Peter Menziuso as its new executive VP and president of BD Interventional, effective June 1.

Menziuso boasts over three decades of global healthcare leadership experience and a track record of driving growth through disciplined execution. He was most recently company group chairman of Johnson & Johnson Vision, where he led a $5 billion global business with responsibility for commercial operations, R&D, supply chain, quality, finance, and medical affairs.

BD said that throughout his career, Menziuso was recognized for bolstering market leadership, building high-performance teams, and translating strategy into sustained performance. The company believes his global leadership experience, customer obsession, and ability to lead at scale position him well to deliver continued growth for BD Interventional.

“BD Interventional has a strong track record of performance, and Peter is the right leader to build on that momentum and continue delivering results,” said Tom Polen, chairman, CEO, and president of BD. “Peter brings a strong combination of strategic leadership and operational discipline. He is grounded in delivering for customers and patients, building strong teams and driving consistent performance, positioning the business for sustained growth and continued strength across the portfolio.”

Last week, the company revealed it had secured European approval for its Revello vascular covered stent, a next-generation endovascular solution for treating atherosclerotic lesions in the common and external iliac arteries.